Test Price
450 AED✅ Home Collection Available
CD45RO (Pan T Cell Marker) Immunohistochemistry Test in UAE | 450 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – Sample collection is arranged via medical courier for archival tissue blocks and biopsy slides; mobile home phlebotomy is disabled for this specimen type.
- Clinical Guidance: Complimentary telephonic post-test consultative support for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The CD45RO immunohistochemistry test is a gold‑standard tissue‑based assay that detects the CD45RO antigen, a marker for memory T‑cells and certain T‑cell lymphomas, enabling precise classification of lymphoid malignancies and immune‑monitoring. In the UAE, this test is performed under DHA‑mandated ISO standards, offering a 5‑day turnaround for routine FFPE blocks and 7 days for large tissue specimens.
| Feature | CD45RO IHC (Our Test) | Routine Histopathology H&E |
|---|---|---|
| Precision | Monoclonal antibody clone UCHL1 – 99.9% sensitivity for memory T‑cells | Morphology only – no immunophenotypic confirmation |
| Methodology | ISO 9001:2015 IHC with automated Leica Bond‑III platform | Manual hematoxylin‑eosin staining |
| Speed | 5 days (FFPE block); 7 days large tissue | 5‑7 days (no added IHC) |
Physician Insight & Safety Protocols
“As a specialist in diagnostic radiology, I emphasize that CD45RO expression must always be correlated with the complete morphological and clinical picture. A positive result does not independently confirm malignancy, and a negative result does not exclude early‑stage lymphoma. Please share all previous biopsies and clinical notes so our team can deliver the most accurate interpretation.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Patient Safety Advisory
Immunohistochemistry results must be interpreted within the full clinical context, including imaging and flow cytometry. Do not discontinue any prescribed medication, especially corticosteroids or immunosuppressants, without explicit consultation with your treating oncologist.
Patient Safety Exclusion & Red Flags
Exclusion Criteria: Non‑consenting individuals, patients with uncorrected coagulopathy (INR >2.5) for fresh biopsy, known severe allergy to local anesthetics, or suspected prion disease – special biosafety protocols required.
Emergency Red Flags: If you experience rapidly enlarging lymph nodes, B‑symptoms (fever, night sweats, weight loss >10%), or severe pain at the biopsy site, seek immediate medical attention rather than waiting for test results.
Patient FAQ & Clinical Guidance
1. What is the CD45RO IHC test used for?
Answer: The CD45RO test identifies memory T‑cell infiltration, aiding diagnosis of T‑cell lymphomas and immune disorders. Subsequent clinical correlation with imaging and flow cytometry is essential for definitive treatment planning, and our post‑test consultation can help you understand the implications.
2. How should I prepare for the tumor tissue submission?
Answer: You do not need to fast; simply ensure the formalin‑fixed tissue block or fresh biopsy in 10% formal‑saline is accompanied by a copy of your histopathology report, biopsy site, and clinical history. Our secure medical courier team will handle transport at room temperature, accepted daily until 6 PM.
3. When will I receive my results and what do they mean?
Answer: Standard FFPE block reports are delivered within 5 days; large complex tissue may take 7 days. A positive CD45RO stain indicates the presence of memory T‑cells, often seen in T‑cell lymphomas but also in reactive conditions, so please discuss all findings with your oncologist to avoid misinterpretation.
UAE Regulatory & Data Privacy Adherence
All procedures adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. This service is licensed under DHA Facility License Number: 1143 and operates within the scope of ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
For insurance verification or home collection booking, contact +971 54 548 8731 via WhatsApp – our support team is available daily from 8 AM to 11 PM.
Clinical & Logistical Metadata
| Test Name | CD45RO (Pan T Cell Marker) Immunohistochemistry |
| Price (AED) | 450 |
| Turnaround Time | 5 Days (Routine FFPE Block) / 7 Days (Large Tissue) |
| Sample Type / Matrix | FFPE Tissue Block or Biopsy Slides (Archival Tissue Specimen) |
| Methodology Used | ISO 9001:2015 IHC with automated Leica Bond‑III platform |
| ICD-10-CM Code | C84.40 (Peripheral T‑cell lymphoma, unspecified) |
| LOINC Code | 33949-0 (CD45RO IHC) |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | License Number: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians